Reduced number and area of tumors. Decreased histoscore tumor burden and the expression of proliferation marker PCNA. Reduced key mediators that link the inflammation with colorectal cancer such as: inflammatory mediator TNF-α, and oncogenic transcription factors STAT3 and NFκB. The gene discussed is PCNA; the disease is neoplasm.